logo efcs bianco

C5: Malignant

This content is also available in: Español Čeština

Bookmark (0)

No account yet? Register

This category indicates an adequate sample showing cells characteristic of carcinoma, or other malignancy. Malignancy should never be diagnosed on the basis of a single criterion. Combinations of the features listed in the following table will be always necessary to achieve the diagnosis.

Criterion Benign Malignant
General characteristics
Cellularity Usually poor or moderate Usually high
Cell to cell cohesion Good with large defined clusters of cells Poor with cell separation resulting in dissociated cells with cytoplasm or small groups of cells
Cell arrangement Even, usually in flat sheets (monolayer) Irregular with overlapping and three-dimensional arrangement
Cell types Mixtures of epithelial, myoepithelial and other cells with fragments of stroma Usually uniform cell population
Bipolar (elliptical) naked nuclei Present, often in high numbers Not conspicuous
Background Generally clean except in inflammatory conditions Occasionally with necrotic debris and sometimes inflammatory cells including macrophages
Nuclear characteristics
Size (in relation to red blood cell (RBC) diameter) Small Variable, often large, depending on tumour type
Pleomorphism Rare Common
Nuclear membranes (Pap stain) Smooth Irregular with indentations
Nucleoli (Pap stain) Indistinct or small and single Variable but may be prominent, large and multiple
Chromatin (Pap stain) Smooth or fine Clumped and may be irregular
Additional features Apocrine metaplasia, foamy macrophages Mucin, intracytoplasmic lumina
(Modified from: GUIDELINES FOR NON-OPERATIVE DIAGNOSTIC PROCEDURES AND REPORTING IN BREAST CANCER SCREENING.  NHSBSP Publication No 50 June 2001).

 

In many other European countries the diagnostic standardization all breast FNA’s cytology specimens is coded using only four reporting categories:

  • Inadequate
  • Benign
  • Suspicious and
  • Malignant.

When European and U.K. classifications are compared there are no differences in “next-step diagnostic procedure” between U.K C3, C4 and C5 categories and suspicious/malignant since histopathological evaluation is required.